List of Schedule V controlled substances (U.S.)
(Redirected from List of Schedule V drugs (US))
This is the list of Schedule V controlled substances in the United States as defined by the Controlled Substances Act.[1] The following findings are required for substances to be placed in this schedule:[2]
- The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV.
- The drug or other substance has a currently accepted medical use in treatment in the United States.
- Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV.
The complete list of Schedule V substances is as follows. The Administrative Controlled Substances Code Number and Federal Register citation for each substance is included.
Opiates and opioids
[edit]| ACSCN | Drug |
|---|---|
| N/A | Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams[3][note 1] |
| N/A | Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams[3][note 1] |
| N/A | Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams[3][note 1] |
| N/A | Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit[3][note 1] |
| N/A | Not more than 100 milligrams of opium per 100 milliliters or per 100 grams[3][note 1] |
| N/A | Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit[4] |
Stimulants
[edit]| ACSCN | Drug |
|---|---|
| 1485 | Pyrovalerone[5] |
Others
[edit]
| ACSCN | Drug |
|---|---|
| 2710 | Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide))[6] |
| 2720 | Cenobamate[7] |
| 2779 | Ezogabine[8] |
| 2401 | Ganaxolone[9] |
| 2746 | Lacosamide[10] |
| 2790 | Lasmiditan[11] |
| 2782 | Pregabalin[12] |
See also
[edit]- List of Schedule I controlled substances (U.S.)
- List of Schedule II controlled substances (U.S.)
- List of Schedule III controlled substances (U.S.)
- List of Schedule IV controlled substances (U.S.)
Notes
[edit]- ^ a b c d e This substance was expressly scheduled by the Controlled Substances Act on October 27, 1970. The 1974 Federal Register ruling (by Administrator John R. Bartels, Jr.) merely organized its listing in the Code of Federal Regulations.
References
[edit]- ^ "21 CFR 1308.15". Code of Federal Regulations. Retrieved September 9, 2023.
- ^ retrieved October 7, 2007
- ^ a b c d e Bartels Jr., John R. (June 20, 1974). "PART 1308— SCHEDULES OF CONTROLLED SUBSTANCES: Annual Publication" (PDF). Government Publishing Office. Drug Enforcement Administration. Archived from the original (PDF) on September 6, 2023. Retrieved September 6, 2023.
- ^ Bensinger, Peter (August 28, 1978). "Placement of Preparations Containing Difenoxin in Combination With Atropine Sulfate Into Schedules IV and V" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on March 3, 2022. Retrieved January 16, 2023.
- ^ Lawn, John (May 4, 1988). "Placement of Propylhexedrine and Pyrovalerone into Schedule V" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on September 26, 2021. Retrieved January 16, 2023.
- ^ Rosenberg, Chuck (March 9, 2017). "Schedules of Controlled Substances: Placement of Brivaracetam Into Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
- ^ Shea, Timothy (August 20, 2020). "Schedules of Controlled Substances: Placement of Cenobamate in Schedule V". Federal Register. Drug Enforcement Administration. Retrieved September 7, 2023.
- ^ Leonhart, Michele (December 15, 2011). "Schedules of Controlled Substances: Placement of Ezogabine Into Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
- ^ Milgram, Anne (November 9, 2022). "Schedules of Controlled Substances: Placement of Ganaxolone in Schedule V". Federal Register. Drug Enforcement Administration. Retrieved September 7, 2023.
- ^ Leonhart, Michele (May 21, 2009). "Schedules of Controlled Substances: Placement of Lacosamide into Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
- ^ Evans, D. Christopher (May 24, 2021). "Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
- ^ Leonhart, Michele (July 28, 2005). "Schedules of Controlled Substances: Placement of Pregabalin Into Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.